rs200353947

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 2P and 16B. PVS1_ModerateBP6_Very_StrongBS1BS2

The NM_181426.2(CCDC39):​c.2660dupT​(p.Ser888IlefsTer6) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0102 in 1,613,166 control chromosomes in the GnomAD database, including 108 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0083 ( 9 hom., cov: 32)
Exomes 𝑓: 0.010 ( 99 hom. )

Consequence

CCDC39
NM_181426.2 frameshift

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 1.53

Publications

8 publications found
Variant links:
Genes affected
CCDC39 (HGNC:25244): (coiled-coil domain 39 molecular ruler complex subunit) The protein encoded by this gene is involved in the motility of cilia and flagella. The encoded protein is essential for the assembly of dynein regulatory and inner dynein arm complexes, which regulate ciliary beat. Defects in this gene are a cause of primary ciliary dyskinesia type 14 (CILD14). [provided by RefSeq, Jul 2011]
TTC14 (HGNC:24697): (tetratricopeptide repeat domain 14) Predicted to enable nucleic acid binding activity. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most 50 bp of the penultimate exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.0587 CDS is truncated, and there are 0 pathogenic variants in the truncated region.
BP6
Variant 3-180616289-T-TA is Benign according to our data. Variant chr3-180616289-T-TA is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 194994.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00827 (1259/152278) while in subpopulation NFE AF = 0.0121 (824/68020). AF 95% confidence interval is 0.0114. There are 9 homozygotes in GnomAd4. There are 587 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 9 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CCDC39NM_181426.2 linkc.2660dupT p.Ser888IlefsTer6 frameshift_variant Exon 19 of 20 ENST00000476379.6 NP_852091.1
TTC14NM_001288582.2 linkc.1775-1090dupA intron_variant Intron 12 of 12 NP_001275511.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CCDC39ENST00000476379.6 linkc.2660dupT p.Ser888IlefsTer6 frameshift_variant Exon 19 of 20 2 NM_181426.2 ENSP00000417960.2

Frequencies

GnomAD3 genomes
AF:
0.00827
AC:
1259
AN:
152160
Hom.:
9
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00224
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00701
Gnomad ASJ
AF:
0.00749
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00228
Gnomad FIN
AF:
0.0156
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0121
Gnomad OTH
AF:
0.0148
GnomAD2 exomes
AF:
0.00792
AC:
1970
AN:
248856
AF XY:
0.00783
show subpopulations
Gnomad AFR exome
AF:
0.00207
Gnomad AMR exome
AF:
0.00349
Gnomad ASJ exome
AF:
0.00736
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0165
Gnomad NFE exome
AF:
0.0114
Gnomad OTH exome
AF:
0.00960
GnomAD4 exome
AF:
0.0104
AC:
15207
AN:
1460888
Hom.:
99
Cov.:
31
AF XY:
0.0103
AC XY:
7464
AN XY:
726708
show subpopulations
African (AFR)
AF:
0.00138
AC:
46
AN:
33438
American (AMR)
AF:
0.00403
AC:
180
AN:
44616
Ashkenazi Jewish (ASJ)
AF:
0.00751
AC:
196
AN:
26108
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39690
South Asian (SAS)
AF:
0.00165
AC:
142
AN:
86244
European-Finnish (FIN)
AF:
0.0168
AC:
896
AN:
53386
Middle Eastern (MID)
AF:
0.00573
AC:
33
AN:
5756
European-Non Finnish (NFE)
AF:
0.0119
AC:
13199
AN:
1111306
Other (OTH)
AF:
0.00853
AC:
515
AN:
60344
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
695
1391
2086
2782
3477
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
488
976
1464
1952
2440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00827
AC:
1259
AN:
152278
Hom.:
9
Cov.:
32
AF XY:
0.00788
AC XY:
587
AN XY:
74458
show subpopulations
African (AFR)
AF:
0.00224
AC:
93
AN:
41550
American (AMR)
AF:
0.00700
AC:
107
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00749
AC:
26
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00228
AC:
11
AN:
4826
European-Finnish (FIN)
AF:
0.0156
AC:
166
AN:
10620
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0121
AC:
824
AN:
68020
Other (OTH)
AF:
0.0147
AC:
31
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
63
125
188
250
313
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0105
Hom.:
7
Bravo
AF:
0.00757
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.0109
EpiControl
AF:
0.0108

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 12, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Primary ciliary dyskinesia Benign:2
Sep 14, 2017
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Oct 02, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CCDC39: BS1, BS2 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.5
Mutation Taster
=128/72
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200353947; hg19: chr3-180334077; COSMIC: COSV106086474; API